Fed. Circ. OKs Endo Win In Testosterone Therapy Patent Case
The Federal Circuit on Friday upheld two patents covering Endo Pharmaceuticals Solutions Inc.'s testosterone replacement therapy Aveed, rejecting a generics maker's argument that the patents were invalid for obviousness....To view the full article, register now.
Already a subscriber? Click here to view full article